Меню
Набор скоро начнётся NCT02837601

Pneumoperitoneum Management With SurgiQuest AirSeal® at Low vs. Higher Pressure

Без фазы С лечением Shoulder Pain

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: AirSeal® Insufflation System (AIS).
Кому может быть актуально
Состояния в реестре: Shoulder Pain. Базовые параметры: до 21 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

A Single Center, Prospective, Randomized, Controlled Study To Evaluate Physician Preference Related To The Use Of The Surgiquest Airseal® Insufflation System (AIS) At Low Vs. Higher Pressure For The Management Of Pneumoperitoneum

Обзор

A prospective, randomized, controlled single-center clinical Study designed to evaluate Physician Preference related to the use of the SurgiQuest AirSeal® Insufflation System (AIS) at low vs. higher pressures for the Management of pneumoperitoneum. Subjects will be randomized in a 1:1 treatment device to control ratio into one of two (2) different study arms: 1. AIS with an insufflation pressure target of 9mmHg ±1mmHg; or 2. AIS with an insufflation pressure target of 15mmHg ±1mmHg.

Подробное описание

The study is designed and powered to demonstrate superiority of the AIS at low pressure vs. at higher pressure on a single key effectiveness measure: Incidence of shoulder pain. Patients will be randomized 1:1 to either AIS with an insufflation pressure target of 9mmHg ±1mmHg or to AIS with an insufflation target pressure of 15mmHg ±1mmHg.

Secondary outcome measures include severity of shoulder pain measured using a VAS scale and medication use, length of hospital stay, aspects of anesthesia management including end tidal CO2 and the frequency of adverse events. These outcomes will be evaluated in a controlled population undergoing laparoscopic surgery.

Вмешательства

  • Устройство AirSeal® Insufflation System (AIS)
    The AirSeal® System consists of an insufflation, filtration, and recirculation system (AirSeal® iFS), a triple lumen filtered tube set, and a valve free trocar (AirSeal® Access Port). The device enables peritoneal access with a novel mechanism to maintain pneumoperitoneum without a mechanical seal. Specifically, the AirSeal® System creates a pressure barrier within the proximal housing of the cannula which acts as an invisible seal to maintain pneumoperitoneum during the course of surgery. It ut

Первичные конечные точки

  • Post-operative shoulder pain [Срок оценки: Post-operative shoulder pain will be assessed at 24 hours after surgery, or at the time of discharge, whichever comes first.]
Вторичные конечные точки (7)
  • Pain severity and trend [Срок оценки: Pain will be assessed at least daily from the immediate post-operative period until discharge from the hospital, up to 10 days.]
  • Pressure stability [Срок оценки: During procedure]
  • Ease of anesthesia management [Срок оценки: During procedure]
  • Length of recovery room stay [Срок оценки: Post-anesthesia care unit (PACU) discharge, up to 24 hours.]
  • Length of Stay (LOS) [Срок оценки: Until the time of hospital discharge, up to 10 days.]
  • Procedural related Adverse Events/ Serious Adverse Events (AEs/ SAEs? [Срок оценки: During hospital stay up to 30 days]
  • Rate of device-related events [Срок оценки: During procedure]

Критерии участия

Критерии включения

  • Pediatric subjects (<21 years of age)
  • > 20 kg in weight;
  • Capable and willing to provide parental Informed Consent and patient Assent;
  • Acceptable candidate for laparoscopic surgery;

Критерии исключения

  • Active cutaneous infection or inflammation;
  • Pre-existing immunodeficiency disorder and/or chronic use of systemic steroids;
  • Uncontrolled diabetes mellitus
  • Known, significant history of bleeding diathesis, coagulopathy, von Willebrand's disease or current platelet count < 100,000 cells/mm3, baseline INR(international normalized ratio) ≥1.8, or fibrinogen level less than 150 mg/dl (if received a fibrinolytic agent within prior 24 hours);
  • Severe co-existing morbidities having a life expectancy of less than 30 days;
  • Currently involved in any other investigational clinical Studies;
  • Significant anemia with a hemoglobin level less than 10 g/dL or a hematocrit less than 30%;
  • Females who are pregnant, planning to become pregnant within 3 months of the procedure, or lactating;
  • Extreme morbid obesity (BMI greater than 45 kg/m2)
  • Patients presenting with Ascites

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Другое

Центры проведения

США · 1 центр
  • Children's Hospital Medical Center of Akron — Akron

Публикации

  • Gurusamy KS, Samraj K, Davidson BR. Low pressure versus standard pressure pneumoperitoneum in laparoscopic cholecystectomy. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006930. doi: 10.1002/14651858.CD006930.pub2. PMID 19370662
  • Hua J, Gong J, Yao L, Zhou B, Song Z. Low-pressure versus standard-pressure pneumoperitoneum for laparoscopic cholecystectomy: a systematic review and meta-analysis. Am J Surg. 2014 Jul;208(1):143-50. doi: 10.1016/j.amjsurg.2013.09.027. Epub 2014 Jan 16. PMID 24503370

Идентификаторы

NCT: NCT02837601 · PRESSURE

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗